Found: 9
Select item for more details and to access through your institution.
Identifying clinically relevant sources of variability: The clopidogrel challenge.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 264, doi. 10.1002/cpt.459
- By:
- Publication type:
- Article
Educational innovations in clinical pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 582, doi. 10.1002/cpt.352
- By:
- Publication type:
- Article
CYP2C19 genotype and cardiovascular events.
- Published in:
- 2012
- By:
- Publication type:
- commentary
A genome-wide linkage scan of insulin level derived traits: the Amish Family Diabetes Study.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes: association analyses in 9,518 subjects.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Clopidogrel pharmacogenetics: Beyond candidate genes and genome-wide association studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 3, p. 323, doi. 10.1002/cpt.519
- By:
- Publication type:
- Article
Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2014, v. 3, n. 7, p. 1, doi. 10.1038/psp.2014.22
- By:
- Publication type:
- Article
The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study.
- Published in:
- 2004
- By:
- Publication type:
- journal article